Barbro Eriksson
About
In The Last Decade
Barbro Eriksson
17 papers receiving 383 citations
Peers
Comparison fields: 5 of 49
- Epidemiology 308
- Oncology 293
- Neurology 244
- Surgery 54
- Pulmonary and Respiratory Medicine 32
Countries citing papers authored by Barbro Eriksson
This map shows the geographic impact of Barbro Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbro Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbro Eriksson more than expected).
Fields of papers citing papers by Barbro Eriksson
This network shows the impact of papers produced by Barbro Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbro Eriksson. The network helps show where Barbro Eriksson may publish in the future.
Co-authorship network of co-authors of Barbro Eriksson
This figure shows the co-authorship network connecting the top 25 collaborators of Barbro Eriksson. A scholar is included among the top collaborators of Barbro Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbro Eriksson. Barbro Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumors | 2 |
| 2 | 71 | |
| 3 | 15 | |
| 4 | 61 | |
| 5 | 18 | |
| 6 | 61 | |
| 7 | 21 | |
| 8 | Whole-body 11C-5-HTP-PET as a general imaging technique for detection of Neuroendocrine tumors - a comparison with somatostatin receptor scintigraphy and computed tomography | 2 |
| 9 | 21 | |
| 10 | Efficacy and Safety of Prolonged-Release Lanreotide in Patients with Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms | 1 |
| 11 | Digestive endocrine tumor management; Medical advanced disease | 0 |
| 12 | Positron emission tomography (PET) with 5-hydroxytryptophan (5-HTP) in the diagnosis and treatment follow upp of carcinoid tumors | 10 |
| 13 | 11 | |
| 14 | 37 | |
| 15 | 9 | |
| 16 | Screening for multiple endocrine neoplasia type 1 syndrome | 0 |
| 17 | Somatostatin receptor scinti-graphy-recent advances concerning imaging of endocrine pancreatic tumors | 2 |
| 18 | Recent advances in the diagnosis and management of endocrine pancreatic tumors | 4 |
| 19 | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.